Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion type Assertion NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_head.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion description "[In contrast, CTGF in patients with poor prognosis (P = 0.021), metastasis (P = 0.012), local recurrence (P = 0.0024) and mortality (P = 0.0072) had markedly reduced levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_provenance.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion evidence source_evidence_literature NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_provenance.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion SIO_000772 15613452 NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_provenance.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion wasDerivedFrom befree-20140225 NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_provenance.
- NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_assertion wasGeneratedBy ECO_0000203 NP203225.RA3By1Al68YOomN8lQyRsIYUNc7cBZ4O3T0TCu-9SBydI130_provenance.